We invite you to participate in a monthly interactive series, modeled after medical grand rounds and molecular tumor boards, which bring together clinical geneticists, molecular pathologists, and genomic scientists to dissect real-world cases that are diagnostically complex or clinically significant. Through expert-led discussions spanning targeted panels to whole genome sequencing and beyond, participants will learn practical strategies for classifying complex variants and incidental findings.
Designed for professionals across genomics and pathology, these sessions deliver applied knowledge grounded in evolving evidence and guidelines, empowering attendees to enhance diagnostic accuracy and clinical decision-making.
What you will learn:
Advanced Variant Interpretation
Frameworks for classifying challenging germline and somatic variants, reviewing real-world case data spanning a range of assay types and applications (rare and undiagnosed disease, hereditary screening, hematopoietic and solid tumor cancers, etc.)
Evidence-Based Decision Making
Integration of ACMG/AMP/ASCO/ESMO guidelines, emerging literature, AI-powered tools, and multiomic data into interpretation strategies.
Case-Based Problem Solving
Visibility into expert strategies for dissecting complex cases in an interactive, discussion-driven format.
Cross-Disciplinary Insights
Perspectives bridging genomics, pathology, and clinical practice for holistic interpretation. Participants are encouraged to bring their complex case questions for collaborative discussion with Illumina Medical Affairs, thought leaders, and peers in a highly interactive forum.
Join us to gain confidence in interpreting challenging genomic cases, elevating your expertise, and transforming complexity into clarity.
Date: January 29, 2026
Time: 8:00 AM PST